Limitations of Long-Term Mortality as a Clinical Trial Endpoint
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference7 articles.
1. Sex differences in all-cause mortality in the decade following complex coronary revascularization;Hara;J Am Coll Cardiol,2020
2. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial;Mohr;Lancet,2013
3. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial;Thuijs;Lancet,2019
4. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II;Farooq;Lancet,2013
5. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data;Head;Lancet,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Search Engines to Capture Missing Deaths From Institutional Data Warehouse;Journal of Surgical Research;2024-02
2. Long-term follow-up after invasive or conservative management of stable coronary disease: the ISCHEMIA-EXTEND study;European Heart Journal Supplements;2023-04-01
3. An invited commentary on ‘Clinical outcomes of early closure versus conservative diagnosis with atrial septal defect: a nationwide population-based cohort study’;European Journal of Cardio-Thoracic Surgery;2022-03-29
4. Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?;European Heart Journal;2021-06-10
5. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis;European Heart Journal;2021-05-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3